cFMS Receptor Inhibitor IV

CAS No. 959626-45-0

cFMS Receptor Inhibitor IV( 5-cyano-N-(2,5-di(piperidin-1-yl)phenyl)furan-2-carboxamide )

Catalog No. M28536 CAS No. 959626-45-0

cFMS Receptor Inhibitor IV is an inhibitor of c-Fms tyrosine kinase.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
2MG 33 In Stock
5MG 53 In Stock
10MG 88 In Stock
25MG 183 In Stock
50MG 276 In Stock
100MG 461 In Stock
200MG Get Quote In Stock
500MG Get Quote In Stock
1G Get Quote In Stock

Biological Information

  • Product Name
    cFMS Receptor Inhibitor IV
  • Note
    Research use only, not for human use.
  • Brief Description
    cFMS Receptor Inhibitor IV is an inhibitor of c-Fms tyrosine kinase.
  • Description
    cFMS Receptor Inhibitor IV is an inhibitor of c-Fms tyrosine kinase.
  • In Vitro
    ——
  • In Vivo
    ——
  • Synonyms
    5-cyano-N-(2,5-di(piperidin-1-yl)phenyl)furan-2-carboxamide
  • Pathway
    Tyrosine Kinase
  • Target
    CSF1R
  • Recptor
    ——
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    959626-45-0
  • Formula Weight
    378.47
  • Molecular Formula
    C22H26N4O2
  • Purity
    >98% (HPLC)
  • Solubility
    In Vitro:?DMSO : 31.25 mg/mL (82.57 mM)
  • SMILES
    N#CC=1OC(=CC1)C(=O)NC2=CC(=CC=C2N3CCCCC3)N4CCCCC4
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

molnova catalog
related products
  • BLZ945

    BLZ945 (BLZ-945) is a potent, selective, brain-penetrant CSF-1R inhibitor with biochemical IC50 of 1 nM.

  • c-FMS-IN-8

    c-FMS-IN-8 is a potent, selective c-FMS kinase inhibitor with IC50 of 0.8 nM, shows activity in collagen-induced model of arthritis in mice.

  • Otilimab

    Otilimab (GSK 3196165) is a humanized monoclonal antibody against granulocyt-macrophage colony-stimulating factor (GM-CSF).